Safety and Efficacy of Iontophoretic Dexamethasone Phosphate Delivery Prior to Implantation of a Posterior Chamber IOL
Status:
Completed
Trial end date:
2012-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and efficacy of ocular iontophoresis with
dexamethasone phosphate ophthalmic solution EGP-437 using the EyeGate® II Drug Delivery
System (EGDS) compared to placebo in patients undergoing cataract surgery with implantation
of a posterior chamber intraocular lens.